MKI67 and ductal breast carcinoma in situ: Herein we demonstrate that the assessment of ERBB2, ESR1, PGR, and MKI67 by MammaTyper in primary tumors remains unaffected by fluctuations in the TCC of FFPE specimens or by the presence of DCIS.